Subscribe
Sign In
Tag: CBT > Cannabis Pharmaceutical Drug
Industry Headlines
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
Led by industry experts, including former GW Pharmaceuticals Director Alan Sutton and genetics and cultivation expert Steven Tan, the program focuses on breeding proprietary plants that are ideal for clinical research and pharmaceutical production.
November 29, 2024
Cannabis Advertising
The Complex Impact of Rescheduling Cannabis on Advertising
The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.
September 17, 2024
Industry Headlines
MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research
The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.
September 11, 2024
Industry Headlines
HYTN Awarded Drug Establishment License from Health Canada, Able to Export Cannabis Pharmaceutical Products Globally
HYTN Innovations Inc., a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds, including cannabis and psilocybin, announces that it has been granted a Drug Establishment License (DEL) by Health Canada.
June 27, 2024
Industry Headlines
Avextra AG and SynQube GmbH Announce a Strategic Partnership in Drug Development With Cannabinoids and Other Psychotropic Substances
June 20, 2024
International
Jamaica Company Ships 1st Legal Exports of THC to United States For DEA Testing
Pure Jamaican elevates Jamaica as a global provider of legal cannabis with pharmaceutical THC product exports to the U.S. and Brazil.
February 22, 2024
Outdoor Cannabis Cultivation
The Pharma Flip
Disenchanted after decades in the pharmaceutical industry, Jason Neely and Brenda Verghese pivoted to cannabis, harnessing their formulation experience to put health and consistency at the forefront of Stratos.
August 10, 2022
International
Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint
This acquisition will accelerate Khiron's growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies.
May 31, 2022
Utah
Pfizer Enters $6.7-Billion Acquisition Deal With Cannabis Pipeline
The American multinational pharmaceutical and biotechnology company signed an agreement with clinical-stage company Arena Pharmaceuticals.
December 21, 2021
CO2 Extraction
Beyond Bag Appeal
Growers pride themselves on their bud’s appearance, but markets exist for cannabis products that don’t necessarily catch the eye.
November 29, 2021
Interviews & Opinion
Cannabis Is Mirroring Pharma: What Industry Pros Should Know
A lot has happened in the world of cannabis legalization since Colorado voters passed Amendment 64 in 2012.
August 2, 2021
Hemp Research
How CBG Can Alleviate Common Symptoms of Cancer Treatment
Preliminary studies have shown how CBG attacks cancer cells, but this minor cannabinoid may improve chemotherapy-related symptoms and quality of life for cancer patients as well.
February 19, 2020
Page 1 of 2
Next Page